| CAS No. | 1818252-53-7 |
|---|---|
| MDL No. | N/A |
| MF | C17H25ClN2O2S |
| MW | 356.90 |
| InChI Key | LEEWMGOHGNRDKC-CTHHTMFSSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 99.84% ; | $438 | In Stock | |
| 5 mg | 99.84% ; | $955 | In Stock | |
| 10 mg | 99.84% ; | $1289 | In Stock | |
| 25 mg | 99.84% ; | $1902 | In Stock | |
| 50 mg | 99.84% ; | $2574 | In Stock | |
| 100 mg | 99.84% ; | $3469 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
TAK-418 is a selective, orally active LSD1 (KDM1A) inhibitor that targets aberrant epigenetic machinery to improve autism symptoms in neurodevelopmental disorder models.
| CAS No. | 1818252-53-7 |
|---|---|
| Product Name | TAK-418 |
| Heavy Atom Count | 23 | Rotatable Bond Count | 6 |
| Atom Stereo Count | 2 | Bond Stereo Count | 0 |
| HBA | 4 | HBD | 2 |
| TPSA | 50.360 Ų | Charge | 0 |
| Exact Mass | 356.13253 | Complexity | 540.45 |
| pKa | 5.875 | XLogP | 2.934 |